Study on Genetic Aberrations in Wild Type GIST Patients in Taiwan
A pilot study aims to evaluate genetic aberrations in wild type GIST patients in Taiwan using an oncopanel test.
Asset / Drug
Drug and asset intelligence for Imatinib with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.